Bicara Therapeutics BCAX
NASDAQ BCAX
$18.51 -0.10 (-0.54%)
As of: Oct 1, 2026 · 11:53 AM EDT

Bicara Therapeutics (BCAX) Other Operating Expenses (2023 - 2025)

Updated

Bicara Therapeutics' Other Operating Expenses was -$6,000 in Q4 2025, compared with -$17,000 a year earlier.

Analysis

Bicara Therapeutics (BCAX) Other Operating Expenses (2023 - 2025) Analysis & Trends

For FY2024, Other Operating Expenses at Bicara Therapeutics came in at $19,000, up 11.8% from FY2023.

  • In earlier years, Other Operating Expenses was $17,000 in FY2023.
  • Quarterly Other Operating Expenses has moved between -$36,000 (Q3 2024) and $62,000 (Q4 2023) over five years.
  • Per Business Quant data, BCAX's Other Operating Expenses in the three quarters before Q4 2025 was -$25,000 (Q3 2025), -$2,000 (Q2 2025) and $33,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bicara Therapeutics 1.23 Bn 1.23 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -6,000.00
Sep 30, 2025 -25,000.00
Jun 30, 2025 -2,000.00
Mar 31, 2025 33,000.00
Dec 31, 2024 -17,000.00
Sep 30, 2024 -36,000.00
Jun 30, 2024 41,000.00
Mar 31, 2024 32,000.00
Dec 31, 2023 62,000.00
Sep 30, 2023 39,000.00
API Access

Bicara Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BCAX&period=max&api_key=YOUR_API_KEY